Literature DB >> 27388331

T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.

Ulf K Radunski1, Gunnar K Lund2, Dennis Säring3, Sebastian Bohnen4, Christian Stehning5, Bernhard Schnackenburg6, Maxim Avanesov2, Enver Tahir2, Gerhard Adam2, Stefan Blankenberg4, Kai Muellerleile4.   

Abstract

INTRODUCTION: This study evaluated the ability of T1 and T2 mapping cardiovascular magnetic resonance (CMR) to detect myocardial injury in apparently normal myocardium of patients with myocarditis.
MATERIALS AND METHODS: We included 20 patients with "infarct-like" acute myocarditis who had typical focal myocardial lesions on late gadolinium enhancement (LGE) images as well as 20 healthy controls. The CMR protocol consisted of a standard myocarditis protocol which was combined with T1 (modified Look-Locker inversion recovery (MOLLI) with a 3(3)5 scheme and T2 mapping (hybrid gradient- and spin-echo multi-echo sequence, GraSE). First, LGE images were used to depict focal myocardial injury and apparently normal, remote myocardium. Second, native T1, T2 and ECV values were obtained in focal lesions but also in apparently normal myocardium. Third, native T1, T2 and ECV values ≥2 standard deviations above reference values obtained in healthy volunteers were used to quantify myocardial injury in patients with myocarditis.
RESULTS: Apparently normal myocardium had significantly higher median native T1 [1095 (1055-1148) ms] and ECV [34 (32-35) %] values compared to reference values from healthy volunteers, which were 1051 (1021-1064) ms (p < 0.01) and 26 (24-27) % (p < 0.0001). Furthermore, a nonsignificant increase in median myocardial T2 was detected in apparently normal myocardium of patients with myocarditis compared to healthy volunteers [59 (55-65) vs. 56 (54-60) ms; p = 0.18]. Consequently, the amount of myocardial injury was significantly larger on native T1 [48 (32-56) %; p < 0.01] and ECV maps [58 (50-66) %; p < 0.01] compared to LGE [14 (9-20) %].
CONCLUSIONS: Native T1 and ECV maps reveal hidden myocardial injury in normal appearing myocardium of patients with myocarditis. The amount of myocardial injury in myocarditis was underestimated by conventional LGE imaging.

Entities:  

Keywords:  ECV imaging; Myocardial injury; Myocarditis; T1 mapping; T2 mapping

Mesh:

Substances:

Year:  2016        PMID: 27388331     DOI: 10.1007/s00392-016-1018-5

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  42 in total

1.  Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis.

Authors:  Christine S Zuern; Britta Walker; Martina Sauter; Malte Schaub; Madhumita Chatterjee; Karin Mueller; Dominik Rath; Sebastian Vogel; Roland Tegtmeyer; Peter Seizer; Tobias Geisler; Reinhard Kandolf; Florian Lang; Karin Klingel; Meinrad Gawaz; Oliver Borst
Journal:  Clin Res Cardiol       Date:  2015-05-26       Impact factor: 5.460

2.  CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis.

Authors:  Marco Francone; Cristina Chimenti; Nicola Galea; Fernanda Scopelliti; Romina Verardo; Roberto Galea; Iacopo Carbone; Carlo Catalano; Francesco Fedele; Andrea Frustaci
Journal:  JACC Cardiovasc Imaging       Date:  2014-02-19

3.  Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging.

Authors:  Heiko Mahrholdt; Anja Wagner; Thomas A Holly; Michael D Elliott; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Circulation       Date:  2002-10-29       Impact factor: 29.690

4.  Diagnostic value of CMR in young patients with clinically suspected acute myocarditis is determined by cardiac enzymes.

Authors:  Anca Florian; Tim Schäufele; Anna Ludwig; Sabine Rösch; Ina Wenzelburger; Handan Yildiz; Udo Sechtem; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2014-10-15       Impact factor: 5.460

5.  Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.

Authors:  Fabian aus dem Siepen; Sebastian J Buss; Florian Andre; Sebastian Seitz; Evangelos Giannitsis; Henning Steen; Hugo A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2015-02-18       Impact factor: 5.460

6.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats.

Authors:  H Arheden; M Saeed; C B Higgins; D W Gao; J Bremerich; R Wyttenbach; M W Dae; M F Wendland
Journal:  Radiology       Date:  1999-06       Impact factor: 11.105

7.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

8.  Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; Cornelia Piper; Olaf Sowade; Finn Waagstein; Joachim-Friedrich Kapp; Karl Wegscheider; Georg Groetzbach; Matthias Pauschinger; Felicitas Escher; Eloisa Arbustini; Harald Siedentop; Uwe Kuehl
Journal:  Clin Res Cardiol       Date:  2016-04-25       Impact factor: 5.460

9.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

Review 10.  T1-mapping in the heart: accuracy and precision.

Authors:  Peter Kellman; Michael S Hansen
Journal:  J Cardiovasc Magn Reson       Date:  2014-01-04       Impact factor: 5.364

View more
  25 in total

1.  Novel CMR techniques enable detection of even mild autoimmune myocarditis in a patient with systemic lupus erythematosus.

Authors:  Michael Bietenbeck; Anca Florian; Zornitsa Shomanova; Karin Klingel; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2017-03-20       Impact factor: 5.460

2.  Left ventricular ejection fraction and presence of myocardial necrosis assessed by cardiac magnetic resonance imaging correctly risk stratify patients with stable coronary artery disease: a multi-center all-comers trial.

Authors:  Dominik Buckert; Sebastian Kelle; Sebastian Buss; Grigorios Korosoglou; Rolf Gebker; Ralf Birkemeyer; Wolfgang Rottbauer; Hugo Katus; Burkert Pieske; Peter Bernhardt
Journal:  Clin Res Cardiol       Date:  2016-10-13       Impact factor: 5.460

Review 3.  Advances in MRI Applications to Diagnose and Manage Cardiomyopathies.

Authors:  Ramya Vajapey; Brendan Eck; Wilson Tang; Deborah H Kwon
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-27

Review 4.  Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging.

Authors:  Giacomo De Luca; Sara Bombace; Lorenzo Monti
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-24       Impact factor: 8.667

5.  Simultaneous Mapping of T1 and T2 Using Cardiac Magnetic Resonance Fingerprinting in a Cohort of Healthy Subjects at 1.5T.

Authors:  Jesse I Hamilton; Shivani Pahwa; Joseph Adedigba; Samuel Frankel; Gregory O'Connor; Rahul Thomas; Jonathan R Walker; Ozden Killinc; Wei-Ching Lo; Joshua Batesole; Seunghee Margevicius; Mark Griswold; Sanjay Rajagopalan; Vikas Gulani; Nicole Seiberlich
Journal:  J Magn Reson Imaging       Date:  2020-03-28       Impact factor: 4.813

6.  Diagnostic and prognostic value of cardiac magnetic resonance in acute myocarditis: a systematic review and meta-analysis.

Authors:  Sarah Blissett; Yehuda Chocron; Bojan Kovacina; Jonathan Afilalo
Journal:  Int J Cardiovasc Imaging       Date:  2019-08-06       Impact factor: 2.357

7.  Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.

Authors:  Paaladinesh Thavendiranathan; Lili Zhang; Amna Zafar; Zsofia D Drobni; Syed S Mahmood; Marcella Cabral; Magid Awadalla; Anju Nohria; Daniel A Zlotoff; Franck Thuny; Lucie M Heinzerling; Ana Barac; Ryan J Sullivan; Carol L Chen; Dipti Gupta; Michael C Kirchberger; Sarah E Hartmann; Jonathan W Weinsaft; Hannah K Gilman; Muhammad A Rizvi; Bojan Kovacina; Caroline Michel; Gagan Sahni; Ana González-Mansilla; Antonio Calles; Francisco Fernández-Avilés; Michael Mahmoudi; Kerry L Reynolds; Sarju Ganatra; Juan José Gavira; Nahikari Salterain González; Manuel García de Yébenes Castro; Raymond Y Kwong; Michael Jerosch-Herold; Otavio R Coelho-Filho; Jonathan Afilalo; Eduardo Zataraín-Nicolás; A John Baksi; Bernd J Wintersperger; Oscar Calvillo-Arguelles; Stephane Ederhy; Eric H Yang; Alexander R Lyon; Michael G Fradley; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2021-03-30       Impact factor: 24.094

Review 8.  Cardiac magnetic resonance fingerprinting: Trends in technical development and potential clinical applications.

Authors:  Brendan L Eck; Scott D Flamm; Deborah H Kwon; W H Wilson Tang; Claudia Prieto Vasquez; Nicole Seiberlich
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-11-06       Impact factor: 9.795

Review 9.  Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail.

Authors:  Summer Hassan; Carolyn J Barrett; David J Crossman
Journal:  Biophys Rev       Date:  2020-07-23

10.  Tissue-tracking in the assessment of late gadolinium enhancement in myocarditis and myocardial infarction.

Authors:  Sara Doimo; Fabrizio Ricci; Nay Aung; Jackie Cooper; Redha Boubertakh; Mihir M Sanghvi; Gianfranco Sinagra; Steffen E Petersen
Journal:  Magn Reson Imaging       Date:  2020-08-25       Impact factor: 3.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.